MediciGlobal News
Most Popular MediciGlobal Story
Service locates lost trial subjects, data
As Avandia maker GlaxoSmithKline (NYSE: GSK) wrestles with the subject and data fallout of the FDA-imposed hold on its TIDE trial, it may want to check in with service provider L2FU, a company that Read more...
Latest Headlines
- July 23, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
